EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Copper redox switching enables glutathione-activated upconversion theranostics

Qiyuan He, Yuxi Liu, Dongju Su, Xiaotian Zhou, Xuanyi Lu, Wenjie Yang, Mingsen Wang, Yunhui Peng, Decai Yang, Lijun Jiang, Guochen Bao

Science China Chemistry · 13.11.2026

DOI: 10.1007/s11426-026-3979-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science China Chemistry, online erschienen am 13.11.2026. Verfasst von Qiyuan He und 10 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor cells often exhibit elevated glutathione (GSH) levels, which maintain redox homeostasis and compromise oxidative stress-based therapeutic strategies. Harnessing this endogenous redox characteristic as an activation trigger for simultaneous molecular sensing and therapeutic intervention remains challenging. Herein, we develop a near-infrared (NIR)-excitable upconversion nanotheranostic platform, UCNPs-P@Cys-Cu, that exploits GSH as an endogenous redox switch for integrated sensing and catalytic therapy. By introducing Cu-S coordination on the surface of upconversion nanoparticles (UCNPs), the nanoplatform is maintained in an OFF state, where coordinated Cu 2+ suppresses upconversion luminescence and remains catalytically inactive. Upon exposure to GSH, Cu 2+ undergoes reductive activation to Cu + , accompanied by disruption of Cu-S coordination, recovery of upconversion luminescence, and activation of Cu + - mediated generation of reactive oxygen species (ROS). This single endogenous trigger simultaneously converts the nanoplatform into a luminescence-on and therapeutically active state. The resulting UCNPs-P@Cys-Cu enables rapid and selective GSH-responsive luminescence recovery with a 65-fold enhancement, while inducing Cu + -triggered ROS-mediated apoptosis, achieving ~96% tumor suppression with negligible systemic toxicity. This work presents an endogenous redoxswitching strategy that transforms GSH from a protective antioxidant into an exploitable molecular trigger for precision cancer theranostics.

Zitieren

APA

He, Q., Liu, Y., Su, D., Zhou, X., Lu, X., Yang, W., Wang, M., Peng, Y., Yang, D., Jiang, L., & Bao, G. (2026). Copper redox switching enables glutathione-activated upconversion theranostics. Science China Chemistry. https://doi.org/10.1007/s11426-026-3979-3

Vancouver

He Q, Liu Y, Su D, Zhou X, Lu X, Yang W, et al. Copper redox switching enables glutathione-activated upconversion theranostics. Science China Chemistry. 2026. doi:10.1007/s11426-026-3979-3

BibTeX
@article{He2026,
  author = {He, Qiyuan and Liu, Yuxi and Su, Dongju and Zhou, Xiaotian and Lu, Xuanyi and Yang, Wenjie and Wang, Mingsen and Peng, Yunhui and Yang, Decai and Jiang, Lijun and Bao, Guochen},
  title = {Copper redox switching enables glutathione-activated upconversion theranostics},
  journal = {Science China Chemistry},
  year = {2026},
  doi = {10.1007/s11426-026-3979-3}
}
Kostenlos starten →